Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „section“
Suchtreffer
Begriffe & Kennungen
Aprovel · 4.8 · Not known: impaired renal function including cases of renal failure in patients at risk (see section 4.4)
Eintrag öffnenAprovel · 4.8 · Not known: impaired renal function including cases of renal failure in patients at risk (see section 4.4)
Eintrag öffnenAptivus · 4.3 · 3 Combination of rifampicin with Aptivus with concomitant low dose ritonavir is contraindicated (see section 4
Eintrag öffnenAptivus · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAptivus · 4.5 · 13 potential towards CYP3A and Aptivus/ritonavir is P-gp. contraindicated (see section 4.3).
Eintrag öffnenAquipta · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 (see section 4.4).
Eintrag öffnenAranesp · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAranesp · 4.8 · Convulsions have been reported in patients receiving darbepoetin alfa (see section 4.4). The frequency is esti
Eintrag öffnenAranesp · 4.8 · Hypertension has been observed in cancer patients in post-marketing experience (see section 4.4). The frequenc
Eintrag öffnenAranesp · 4.8 · Stroke was reported as common in CRF patients in TREAT (see section 5.1).
Eintrag öffnenArava · 4.3 · • Breast-feeding women (see section 4.6).
Eintrag öffnenArava · 4.3 · • Breast-feeding women (see section 4.6).
Eintrag öffnenArava · 4.3 · • Breast-feeding women (see section 4.6).
Eintrag öffnenArava · 4.3 · • Patients with serious infections (see section 4.4).
Eintrag öffnenArava · 4.3 · • Patients with serious infections (see section 4.4).
Eintrag öffnenArava · 4.3 · • Patients with serious infections (see section 4.4).
Eintrag öffnenArexvy · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenAripiprazole Sandoz · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenArixtra · 4.3 · - hypersensitivity to the active substance or to any of the excipients listed in section 6.1 - active clinical
Eintrag öffnenArixtra · 4.3 · - hypersensitivity to the active substance or to any of the excipients listed in section 6.1 - active clinical
Eintrag öffnen